Biotech Takeover Targets Wall Street Eyes After Apogee Deal
AbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
Guide to which stablecoins offer staking rewards and how to participate to start earning rewards efficiently.
21,681 articlesAbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
When Goldman Sachs raises its dividend as advisory and underwriting fees rebound, investors take notice. This article...
A sharp month-long sell-off pushed AeroVironment shares down by more than 20%. This article breaks down the catalysts...
A bold 17-inch Wimbledon hat by a global star sparked more than fashion chatter — it raised real questions about cost...
A public image can swing earnings as fast as headlines. This article examines how scandals reshape money, plus concre...
Imagine moving to a new home without starting a new loan at a higher rate. Portable mortgages could make that possibl...
Markets have celebrated a long rally, but chair nominee kevin warsh's real test may lie in credibility, independence,...
A booming memory era presents both opportunities and risks for Micron. This guide breaks down the potential, the cata...
This guide shows investors how to interpret earnings transcripts for natural gas services. It covers key metrics, rea...
Microsoft shares fell Tuesday as investors reassessed the cost of OpenAI bets and growing capital needs, even after a...
A clear guide to reading RMTI's Q1 2026 earnings call, what the numbers mean, and how to spot the catalysts that can ...
Biotech earnings chants are rarely about profits for small developers. This guide explains how to read Celcuity's 202...